Watts, Colin, Dayimu, Alimu, Matys, Tomasz, Ashkan, Keyoumars, Price, Stephen, Jenkinson, Michael DD 
ORCID: 0000-0003-4587-2139, Doughton, Gail, Mather, Claire, Young, Gemma, Qian, Wendi et al (show 1 more authors)
(2023)
Refining the Intraoperative Identification of Suspected High-Grade Glioma Using a Surgical Fluorescence Biomarker: GALA BIDD Study Report.
JOURNAL OF PERSONALIZED MEDICINE, 13 (3).
514-.
Abstract
<h4>Background</h4>Improving intraoperative accuracy with a validated surgical biomarker is important because identifying high-grade areas within a glioma will aid neurosurgical decision-making and sampling.<h4>Methods</h4>We designed a multicentre, prospective surgical cohort study (GALA-BIDD) to validate the presence of visible fluorescence as a pragmatic intraoperative surgical biomarker of suspected high-grade disease within a tumour mass in patients undergoing 5-aminolevulinic acid (5-ALA) fluorescence-guided cytoreductive surgery.<h4>Results</h4>A total of 106 patients with a suspected high-grade glioma or malignant transformation of a low-grade glioma were enrolled. Among the 99 patients who received 5-ALA, 89 patients were eligible to assess the correlation of fluorescence with diagnosis as per protocol. Of these 89, 81 patients had visible fluorescence at surgery, and 8 patients had no fluorescence. A total of 80 out of 81 fluorescent patients were diagnosed as high-grade gliomas on postoperative central review with 1 low-grade glioma case. Among the eight patients given 5-ALA who did not show any visible fluorescence, none were high-grade gliomas, and all were low-grade gliomas. Of the seven patients suspected radiologically of malignant transformation of low-grade gliomas and with visible fluorescence at surgery, six were diagnosed with high-grade gliomas, and one had no tissue collected.<h4>Conclusion</h4>In patients where there is clinical suspicion, visible 5-ALA fluorescence has clinical utility as an intraoperative surgical biomarker of high-grade gliomas and can aid surgical decision-making and sampling. Further studies assessing the use of 5-ALA to assess malignant transformation in all diffuse gliomas may be valuable.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | 5ALA, fluorescence, intraoperative biomarker |
| Divisions: | Faculty of Health and Life Sciences Faculty of Health and Life Sciences > Institute of Systems, Molecular and Integrative Biology |
| Depositing User: | Symplectic Admin |
| Date Deposited: | 20 Apr 2023 08:22 |
| Last Modified: | 20 Apr 2023 08:22 |
| DOI: | 10.3390/jpm13030514 |
| Open Access URL: | https://doi.org/10.3390/jpm13030514 |
| Related URLs: | |
| URI: | https://livrepository.liverpool.ac.uk/id/eprint/3169803 |
Dimensions
Dimensions
